Skip to main content
Top

Current Oncology Reports

Issue 8/2018

Content (8 Articles)

Gastrointestinal Cancers (J Meyer, Section Editor)

Peritoneal Metastases from Gastrointestinal Cancer

Paul H. Sugarbaker

Integrative Care (C Lammersfeld, Section Editor)

Flaxseed Bioactive Compounds and Colorectal Cancer Prevention

Jennifer A. A. DeLuca, Erika L. Garcia-Villatoro, Clinton D. Allred

Integrative Care (C Lammersfeld, Section Editor)

Toxicity of Cancer Therapies in Older Patients

Olivia Le Saux, Claire Falandry

Neuro-oncology (S Nagpal, Section Editor)

The Utility of Liquid Biopsy in Central Nervous System Malignancies

Kathryn S. Nevel, Jessica A. Wilcox, Lindsay J. Robell, Yoshie Umemura

Cardio-oncology (EH Yang, Section Editor)

Tyrosine Kinase Inhibitor-Induced Hypertension

Megha Agarwal, Nidhi Thareja, Melody Benjamin, Andre Akhondi, George D. Mitchell

Breast Cancer (B Overmoyer, Section Editor)

Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?

Narjust Duma, Kelly C. Gast, Grace M. Choong, Roberto A. Leon-Ferre, Ciara C. O’Sullivan

Breast Cancer (B Overmoyer, Section Editor)

Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?

Jesse Caron, Anju Nohria

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Molecular Subtypes of Prostate Cancer

Kaveri Arora, Christopher E. Barbieri

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine